Abbott To Buy Solvay's Pharma Unit For $6.6B Cash
Abbott Laboratories plans to buy the pharmaceutical business of Belgium's Solvay Group for $6.6 billion in cash in a move to expand its presence in key emerging markets and diversify its...To view the full article, register now.
Already a subscriber? Click here to view full article